Business Description
Artrya Ltd
ISIN : AU0000182412
Description
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 169.25 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 192.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | 11.8 | |||||
3-Year FCF Growth Rate | 13.4 | |||||
3-Year Book Growth Rate | -28.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 45.91 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 728.28 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.05 | |||||
9-Day RSI | 56.95 | |||||
14-Day RSI | 51.85 | |||||
3-1 Month Momentum % | 6.14 | |||||
6-1 Month Momentum % | 70.7 | |||||
12-1 Month Momentum % | 282.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 37.11 | |||||
Quick Ratio | 37.11 | |||||
Cash Ratio | 33 | |||||
Days Sales Outstanding | 24780.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.1 | |||||
Shareholder Yield % | -11.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -33461.45 | |||||
Net Margin % | -23744.58 | |||||
EBITDA Margin % | -29600 | |||||
FCF Margin % | -25757.83 | |||||
OCF Margin % | -25402.41 | |||||
ROE % | -47.18 | |||||
ROA % | -44.61 | |||||
ROIC % | -248.61 | |||||
3-Year ROIIC % | -129.23 | |||||
ROC (Joel Greenblatt) % | -587.57 | |||||
ROCE % | -60.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4950 | |||||
PB Ratio | 8.76 | |||||
Price-to-Tangible-Book | 9.17 | |||||
EV-to-EBIT | -27.99 | |||||
EV-to-Forward-EBIT | -64.6 | |||||
EV-to-EBITDA | -28.92 | |||||
EV-to-Forward-EBITDA | -78.95 | |||||
EV-to-Revenue | 8561.16 | |||||
EV-to-Forward-Revenue | 41.8 | |||||
EV-to-FCF | -33.24 | |||||
| Price-to-Net-Current-Asset-Value | 9.34 | |||||
| Price-to-Net-Cash | 10.53 | |||||
Earnings Yield (Greenblatt) % | -3.57 | |||||
FCF Yield % | -2.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Artrya Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.083 | ||
| EPS (TTM) (A$) | -0.172 | ||
| Beta | 1.5992 | ||
| 3-Year Sharpe Ratio | 1.22 | ||
| 3-Year Sortino Ratio | 3.4 | ||
| Volatility % | 130.47 | ||
| 14-Day RSI | 51.85 | ||
| 14-Day ATR (A$) | 0.355497 | ||
| 20-Day SMA (A$) | 4.78 | ||
| 12-1 Month Momentum % | 282.86 | ||
| 52-Week Range (A$) | 1.225 - 6.49 | ||
| Shares Outstanding (Mil) | 163.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Artrya Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Artrya Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Artrya Ltd Frequently Asked Questions
What is Artrya Ltd(ASX:AYA)'s stock price today?
The current price of ASX:AYA is A$4.95. The 52 week high of ASX:AYA is A$6.49 and 52 week low is A$1.23.
When is next earnings date of Artrya Ltd(ASX:AYA)?
The next earnings date of Artrya Ltd(ASX:AYA) is .
Does Artrya Ltd(ASX:AYA) pay dividends? If so, how much?
Artrya Ltd(ASX:AYA) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| FDA clearance of Salix® Coronary Plaque module | 2025-08-21 | ||
| ARTRYA OPENS US OPERATIONS IN LOS ANGELES | 2022-03-29 | ||
| ARTRYA APPOINTS RENOWNED EXECUTIVE DR JACQUE SOKOLOV AS UNITED STATES ADVISOR | 2022-01-13 |
Articles on Artrya Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers